← Open Payments lookup

ANITA SCHIERLINGER: Open Payments

NPI 1720220312 · NORTH BRANCH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$636 in 34 payments from 13 companies in 2025. Trend: 2023 $517 · 2024 $598 · 2025 $636

Food & beverage: $636
CompanyPaymentsAmount
Novo Nordisk Inc10$164
ABBVIE INC.4$90
Otsuka America Pharmaceutical, Inc.3$67
Supernus Pharmaceuticals, Inc.3$59
AstraZeneca Pharmaceuticals LP2$40
GlaxoSmithKline, LLC.2$40
Exact Sciences Corporation2$33
Axsome Therapeutics, Inc.1$33
Lilly USA, LLC2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: Wegovy, REXULTI, Qelbree, VRAYLAR, TRELEGY ELLIPTA, Auvelity, MOUNJARO, CAPLYTA.

Industry payments across MI — which companies pay providers there.